B6;SJL-Tg(Mt1-SERPINE1)1Upj/Cnrm

Status

Available to order

EMMA IDEM:04468
International strain nameB6;SJL-Tg(Mt1-SERPINE1)1Upj/Cnrm
Alternative namePAI-1
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Mt1-SERPINE1)1Upj,
Gene/Transgene symbolTg(Mt1-SERPINE1)1Upj

Information from provider

ProviderAndreina Poggi
Provider affiliationConsorzio Mario Negri Sud
Additional ownerDr. Laurence A. Erickson and Dr. Keith R. Marotti, Pfizer (former Upjohn), Kalamazoo, MI, U.S.A.
Genetic informationThe DNA construct used in the production of SERPINE1 (PAI-1) transgenic mice contained the metallothionein I promoter, human endothelial cell SERPINE1 complementary DNA, and the bovine growth hormone polyadenylation sequence.
Phenotypic informationMice putatively transgenic for human SERPINE1 (PAI-1) showed a single, early indication of disturbance of the haemostatic system. A distinct area of subcutaneous haemorrhage was apparent at tail's tip of mice at 3 days after birth, followed by necrosis and swollen hind feet at about 12 days, as a result of venous occlusion and oedema. At about 2 weeks of age, the necrotic portion of the tail completely sloughed off, whereas the swollen hind limbs appeared normal.
Breeding historySERPINE1 (PAI-1) transgenic mice originally obtained from Dr. L.A. Erickson, The Upjohn Company, Kalamazoo, Michigan USA, were backcrossed for 4 generations to C57BL/6 mice; mice were subsequently intercrossed (brother x sister) for more than 100 generations.
References
  • Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene.;Erickson L A, Fici G J, Lund J E, Boyle T P, Polites H G, Marotti K R, ;1990;Nature;346;74-6; 2366866
  • Immunohistochemical localization of fibrinolytic proteins in tissues from human PAI gene transgenic mice;Salvatore L, Iacoviello L, Bellelli E, Poggi A, Donati MB;1995;Thrombosis and Haemostasis (Abstracts);73;1005;
  • A simple and reproducible model of arterial injury in normal and PAI-1 transgenic mice;Di Sciullo A, Mironov A, Nasuti M, Di Nardo P, Poggi A;1995;Thrombosis and Haemostasis (Abstracts);73;1333;
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Literature references

  • Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene.;Erickson L A, Fici G J, Lund J E, Boyle T P, Polites H G, Marotti K R, ;1990;Nature;346;74-6; 2366866
  • Immunohistochemical localization of fibrinolytic proteins in tissues from human PAI gene transgenic mice;Salvatore L, Iacoviello L, Bellelli E, Poggi A, Donati MB;1995;Thrombosis and Haemostasis (Abstracts);73;1005;
  • A simple and reproducible model of arterial injury in normal and PAI-1 transgenic mice;Di Sciullo A, Mironov A, Nasuti M, Di Nardo P, Poggi A;1995;Thrombosis and Haemostasis (Abstracts);73;1333;

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).